SINTX Technologies

SINTX Technologies AAQS

The The AAQS of SINTX Technologies (SINT) as of Oct 26, 2026 is 4. In the previous year, The AAQS was 4.00 — a change of 0.00% (lower).

AAQS

4

YoY

0.00%

Last updated:

SINTX Technologies has a current AAQS of 4.

A high AAQS can be seen as a positive indicator that the company is developing successfully.

Investors can assume that the company is on a good path to generate profits.

On the other hand, it is important to consider the AAQS of the stock SINTX Technologies in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.

In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.

The SINTX Technologies AAQS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

AAQS
Date
AAQS
Jan 1, 2018
4.00 USD
Jan 1, 2019
4.00 USD
Jan 1, 2020
4.00 USD
Jan 1, 2021
4.00 USD
Jan 1, 2022
4.00 USD
Jan 1, 2023
4.00 USD
Jan 1, 2024
4.00 USD
Jan 1, 2025
4.00 USD
The SINTX Technologies AAQS history
YEARAAQSYoY
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
4—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SINTX Technologies Stock analysis

What does SINTX Technologies do? SINTX Technologies, Inc. generates revenue by manufacturing and selling silicon nitride-based orthopedic medical devices. The company focuses on vertically integrated production of silicon nitride ceramic technology for hip and knee arthroplasty components, including solid, porous, composite, and coated forms. Its primary customers are surgeons and hospitals in the United States, Europe, and South America, who purchase these wear- and corrosion-resistant implant components for total hip and knee replacement procedures. The firm markets its products directly to healthcare providers through its established distribution channels in target markets. The company's revenue stream is derived from the sale of silicon nitride ceramic technology platforms used in medical devices, with a specific emphasis on orthopedic applications. By developing and producing implant components that incorporate silicon nitride, SINTX addresses the need for durable, high-performance materials in joint replacement surgeries. This approach allows the company to target the growing market for advanced orthopedic solutions in key regions. SINTX Technologies, Inc. operates as a commercial biomaterial company specializing in silicon nitride ceramic technology. Its product portfolio includes components for total hip and knee replacement systems, which are sold to healthcare institutions globally. The firm's vertically integrated manufacturing model ensures control over the production of silicon nitride materials, enabling consistent quality and innovation in its medical device offerings. SINTX Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SINTX Technologies stock

The AAQS of SINTX Technologies is 4 in 2025.

On Eulerpool you can find the complete historical development of The AAQS SINTX Technologies since 2006 – with annual values, charts, and detailed analysis.

The AAQS is a key figure developed by AlleAktien.

The AAQS is a key figure developed by AlleAktien.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — SINTX Technologies

All Key Metrics — SINTX Technologies